Ofran, Yishai
43  results:
Search for persons X
?
2

Chasing quality remission in acute myeloid leukemia: intens..:

Ofran, Yishai
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388263/.  , 2023
 
?
3

Is it time for age and clinically adjusted minimal residual..:

Ofran, Yishai
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772512/.  , 2023
 
?
11

Implementation of data protection laws in the European Unio..:

Yom-Tov, Elad ; Ofran, Yishai
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685308/.  , 2022
 
?
13

2021 Update on MRD in acute myeloid leukemia:a consensus do..:

Heuser, Michael ; Freeman, Sylvie D ; Ossenkoppele, Gert J...
Heuser , M , Freeman , S D , Ossenkoppele , G J , Buccisano , F , Hourigan , C S , Ngai , L L , Tettero , J M , Bachas , C , Baer , C , Béné , M C , Bücklein , V , Czyz , A , Denys , B , Dillon , R , Feuring-Buske , M , Guzman , M L , Haferlach , T , Han , L , Herzig , J K , Jorgensen , J L , Kern , W , Konopleva , M Y , Lacombe , F , Libura , M , Majchrzak , A , Maurillo , L , Ofran , Y , Philippe , J , Plesa , A , Preudhomme , C , Ravandi , F , Roumier , C , Subklewe , M , Thol , F , van de Loosdrecht , A A , van der Reijden , B A , Venditti , A , Wierzbowska , A , Valk , P J M , Wood , B L , Walter , R B , Thiede , C , Döhner , K , Roboz , G J & Cloos , J 2021 , ' 2021 Update on MRD in acute myeloid leukemia : a consensus document from the European LeukemiaNet MRD Working Party ' , Blood , vol. 138 , no. 26 , pp. 2753-2767 . https://doi.org/10.1182/blood.2021013626.  , 2021
 
?
14

2021 Update on MRD in acute myeloid leukemia:a consensus do..:

Heuser, Michael ; Freeman, Sylvie D ; Ossenkoppele, Gert J...
Heuser , M , Freeman , S D , Ossenkoppele , G J , Buccisano , F , Hourigan , C S , Ngai , L L , Tettero , J M , Bachas , C , Baer , C , Béné , M C , Buecklein , V , Czyz , A , Denys , B , Dillon , R , Feuring-Buske , M , Guzman , M L , Haferlach , T , Han , L , Herzig , J K , Jorgensen , J L , Kern , W , Konopleva , M Y , Lacombe , F , Libura , M , Majchrzak , A , Maurillo , L , Ofran , Y , Philippé , J , Plesa , A , Preudhomme , C , Ravandi , F , Roumier , C , Subklewe , M , Thol , F , van de Loosdrecht , A A , van der Reijden , B A , Venditti , A , Wierzbowska , A , Valk , P J M , Wood , B L , Walter , R B , Thiede , C , Döhner , K , Roboz , G J & Cloos , J 2021 , ' 2021 Update on MRD in acute myeloid leukemia : a consensus document from the European LeukemiaNet MRD Working Party ' , Blood , vol. 138 , no. 26 , pp. 2753-2767 . https://doi.org/10.1182/blood.2021013626.  , 2021
 
?
15

Efficacy and Safety Profile of Ivosidenib in the Management..:

Stemer, Galia ; Rowe, Jacob M ; Ofran, Yishai
info:eu-repo/semantics/altIdentifier/doi/10.2147/BLCTT.S236446.  , 2021
 
1-15